 |
Video: What is a Stock Split?
|
 |
Xtant Medical Holdings, Inc. is a global medical technology company. Co. is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. According to our XTNT split history records, Xtant Medical Holdings has had 1 split. | |
 |

Xtant Medical Holdings (XTNT) has 1 split in our XTNT split history database. The split for XTNT took place on February 14, 2018. This was a 1 for 12 reverse split, meaning for each 12 shares of XTNT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 83.3333333333333 share position following the split.
When a company such as Xtant Medical Holdings conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the XTNT split history from start to finish, an original position size of 1000 shares would have turned into 83.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Xtant Medical Holdings shares, starting with a $10,000 purchase of XTNT, presented on a split-history-adjusted basis factoring in the complete XTNT split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2015 |
|
End date: |
04/25/2025 |
|
Start price/share: |
$51.00 |
|
End price/share: |
$0.51 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.00% |
|
Average Annual Total Return: |
-36.91% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$100.04 |
|
Years: |
10.00 |
|
|
 |
Date |
Ratio |
02/14/2018 | 1 for 12 |
|
 |